GlobeStar Therapeutics Corporation

Share · US37960P1049 (OTC)

Overview

No Price

Closing Price OTC 29.01.2026: 0,0001 USD

29.01.2026 21:00

Current Prices from GlobeStar Therapeutics Corporation

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
UTC	GSTC	USD	29.01.2026 21:00	0,0001 USD	0,00 USD

Company Profile for GlobeStar Therapeutics Corporation Share

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is based in Richland, Washington.

AI Analysis of GlobeStar Therapeutics Corporation

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of GlobeStar Therapeutics Corporation

No AI threads available for this company yet.

Company Data

Name GlobeStar Therapeutics Corporation

Company GlobeStar Therapeutics Corporation

Website https://www.globestarthera.com

Primary Exchange

UTC

ISIN US37960P1049

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO James C. Katzaroff

Country United States of America

Currency USD

Employees -

Address 719 Jadewin Avenue, 99352 Richland

IPO Date 2011-09-26

Ticker Symbols

Name	Symbol
Over The Counter	GSTC

More Shares

Investors who hold GlobeStar Therapeutics Corporation also have the following shares in their portfolio:

FRONTIER COMMUNICTS 2046 Bond

Northern Lights Fund Trust IV Main International ETF ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog